Differential regulation of macropinocytosis in macrophages by cytokines: Implications for foam cell formation and atherosclerosis

Cytokine

Volumn 64, Issue 1, 2013, Pages 357-361

  Michael, Daryn R ^a   Ashlin, Tim G ^a   Davies, Charlotte S ^a   Gallagher, Hayley ^a   Stoneman, Thomas W ^a   Buckley, Melanie L ^a   Ramji, Dipak P ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Atherosclerosis; Cytokine; Foam cell; Low density lipoprotein; Macropinocytosis

Indexed keywords

CYTOCHALASIN D; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 33; LOW DENSITY LIPOPROTEIN; SCAVENGER RECEPTOR; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ADENOVIRUS INFECTION; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DISEASE COURSE; FOAM CELL; HUMAN; HUMAN CELL; INTERNALIZATION; MACROPHAGE; MONOCYTE; PINOCYTOSIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM;

1,1-DIOCTADECYL-3,3,3′,3′-TETRAMETHYLINDOCARBOCYANE PERCHLORATE; ACETYLATED LDL; ACLDL; APO; APOLIPOPROTEIN; ATHEROSCLEROSIS; BMDM; BONE MARROW-DERIVED MACROPHAGE; CD-36; CLUSTER OF DIFFERENTIATION 36; CYTOKINE; DII; FOAM CELL; GAPDH; GLYCERALDEHYDE 3-PHOSPHATE DEHYDROGENASE; HMDM; HUMAN ACUTE MONOCYTIC LEUKEMIA CELLS; HUMAN MONOCYTE-DERIVED MACROPHAGES; IFN-Γ; IL; INTERFERON-Γ; INTERLEUKIN; LDL; LOW DENSITY LIPOPROTEIN; LOW-DENSITY LIPOPROTEINS; LUCIFER YELLOW; LY; MACROPINOCYTOSIS; OXIDIZED LDL; OXLDL; SCAVENGER RECEPTOR A; SHORT HAIRPIN RNA; SHRNA; SR-A; TGF-Β; THP-1; TRANSFORMING GROWTH FACTOR-Β;

ATHEROSCLEROSIS; BIOLOGICAL TRANSPORT; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOCHALASIN D; FOAM CELLS; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE (PHOSPHORYLATING); HUMANS; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKINS; LIPOPROTEINS, LDL; MACROPHAGES; NUCLEIC ACID SYNTHESIS INHIBITORS; PINOCYTOSIS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 84883558522     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2013.05.016     Document Type: Article

References (30)

1. McLaren J.E., Michael D.R., Ashlin T.G., Ramji D.P. Cytokines, macrophage lipid metabolism and foam cells: implications for cardiovascular disease therapy. Prog Lipid Res 2011, 50:331-347.
2. Michael D.R., Ashlin T.G., Buckley M.L., Ramji D.P. Macrophages, lipid metabolism and gene expression in atherogenesis: a therapeutic target of the future?. Clin Lipidol 2012, 7:37-48.
3. McLaren J.E., Michael D.R., Salter R.C., Ashlin T.G., Calder C.J., Miller A.M., et al. IL-33 reduces macrophage foam cell formation. J Immunol 2010, 185:1222-1229.
4. Li N., McLaren J.E., Michael D.R., Clement M., Fielding C.A., Ramji D.P. ERK is integral to the IFN-γ-mediated activation of STAT1, the expression of key genes implicated in atherosclerosis, and the uptake of modified lipoproteins by human macrophages. J Immunol 2010, 185:3041-3048.
5. Irvine S.A., Foka P., Rogers S.A., Mead J.R., Ramji D.P. A critical role for the Sp1-binding sites in the transforming growth factor-beta-mediated inhibition of lipoprotein lipase gene expression in macrophages. Nucl Acids Res 2005, 33:1423-1434.
6. Kruth H.S., Huang W., Ishii I., Zhang W.Y. Macrophage foam cell formation with native low density lipoprotein. J Biol Chem 2002, 277:34573-34580.
7. Jones N., Willingham M. Modified LDLs are internalized by macrophages in part via macropinocytosis. Anat Rec 1999, 255:57-68.
8. Racoosin E., Swanson J. Macropinosome maturation and fusion with tubular lysosomes in macrophages. J Cell Biol 1993, 121:1011-1020.
9. Yao W., Li K., Liao K. Macropinocytosis contributes to the macrophage foam cell formation in RAW2647 cells. Acta Biochim Biophys Sin 2009, 41:773-780. [Shanghai].
10. Buono C., Anzinger J.J., Amar M., Kruth H.S. Fluorescent pegylated nanoparticles demonstrate fluid-phase pinocytosis by macrophages in mouse atherosclerotic lesions. J Clin Invest 2009, 119:1373-1381.
11. Kruth H., Jones N., Huang W., Zhao B., Ishii I., Chang J., et al. Macropinocytosis is the endocytic pathway that mediates macrophage foam cell formation with native low density lipoprotein. J Biol Chem 2005, 280:2352-2360.
12. Zhao B., Li Y., Buono C., Waldo S.W., Jones N.L., Mori M., et al. Constitutive receptor-independent low density lipoprotein uptake and cholesterol accumulation by macrophages differentiated from human monocytes with macrophage-colony-stimulating factor (M-CSF). J Biol Chem 2006, 281:15757-15762.
13. Anzinger J.J., Chang J., Xu Q., Buono C., Li Y., Leyva F.J., et al. Native low-density lipoprotein uptake by macrophage colony-stimulating factor-differentiated human macrophages is mediated by macropinocytosis and micropinocytosis. Arterioscler Thromb Vasc Biol 2010, 30:2022-2031.
14. Miller Y.I., Choi S.H., Wiesner P., Bae Y.S. The SYK side of TLR4: signalling mechanisms in response to LPS and minimally oxidized LDL. Br J Pharmacol 2012, 167:990-999.
15. Choi S.H., Harkewicz R., Lee J.H., Boullier A., Almazan F., Li A.C., et al. Lipoprotein accumulation in macrophages via toll-like receptor-4-dependent fluid phase uptake. Circ Res 2009, 104:1355-1363.
16. Grewal T., Priceputu E., Davignon J., Bernier L. Identification of a gamma-interferon-responsive element in the promoter of the human macrophage scavenger receptor A gene. Arterioscler Thromb Vasc Biol 2001, 21:825-831.
17. Steinberg T.H., Newman A.S., Swanson J.A., Silverstein S.C. ATP4-permeabilizes the plasma membrane of mouse macrophages to fluorescent dyes. J Biol Chem 1987, 262:8884-8888.
18. Draude G., Lorenz R. TGF-beta1 downregulates CD36 and scavenger receptor A but upregulates LOX-1 in human macrophages. Am J Physiol Heart Circ Physiol 2000, 278:H1042-H1048.
19. Michael D.R., Salter R.C., Ramji D.P. TGF-β inhibits the uptake of modified low density lipoprotein by human macrophages through a Smad-dependent pathway: a dominant role for Smad-2. Biochim Biophys Acta 2012, 1822:1608-1616.
20. Auwerx J. The human leukemia cell line, THP-1: a multifacetted model for the study of monocyte-macrophage differentiation. Experientia 1991, 47:22-31.
21. Swanson J. Phorbol esters stimulate macropinocytosis and solute flow through macrophages. J Cell Sci 1989, 94(Pt 1):135-142.
22. Goldstein J., Ho Y., Basu S., Brown M. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci USA 1979, 76:333-337.
23. Smith E., Prasad K.M., Butcher M., Dobrian A., Kolls J.K., Ley K., et al. Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice. Circulation 2010, 121:1746-1755.
24. McLaren J.E., Calder C.J., McSharry B.P., Sexton K., Salter R.C., Singh N.N., et al. The TNF-like protein 1A-death receptor 3 pathway promotes macrophage foam cell formation in vitro. J Immunol 2010, 184:5827-5834.
25. Hutchinson D.S., Evans B.A., Summers R.J. Beta(1)-adrenoceptors compensate for beta(3)-adrenoceptors in ileum from beta(3)-adrenoceptor knock-out mice. Br J Pharmacol 2001, 132:433-442.
26. Lee G.S., Lee K.Y., Choi K.C., Ryu Y.H., Paik S.G., Oh G.T., et al. Phenotype of a calbindin-D9k gene knockout is compensated for by the induction of other calcium transporter genes in a mouse model. J Bone Miner Res 2007, 22:1968-1978.
27. McLaren J.E., Michael D.R., Guschina I.A., Harwood J.L., Ramji D.P. Eicosapentaenoic acid and docosahexaenoic acid regulate modified LDL uptake and macropinocytosis in human macrophages. Lipids 2011, 46:1053-1061.
28. Erbel C., Chen L., Bea F., Wangler S., Celik S., Lasitschka F., et al. Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice. J Immunol 2009, 183:8167-8175.
29. McLaren J.E., Ramji D.P. Interferon gamma: a master regulator of atherosclerosis. Cytok Growth Factor Rev. 2009, 20:125-135.
30. Singh N.N., Ramji D.P. The role of transforming growth factor-beta in atherosclerosis. Cytok Growth Factor Rev 2006, 17:487-499.